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Abstract
Background: Most patients with head and neck cancers in our environment present late and
usually first to the general surgeons whose practice is to subject these patients to open cervical
lymph node biopsy without a prior examination under anesthesia and endoscopic biopsy from the
primary tumor site in order to obtain a histological diagnosis.
This paper presents the influence of open cervical lymph node biopsy on the clinical outcome of
patients with head and neck cancers in our environment.
Methods: This is a ten-year retrospective review of patients with head and neck cancers in the Jos
University Teaching Hospital, Jos, Nigeria.
Results: Eighty nine patients aged between 23 and 78 years had head and neck cancers with 38/89
(42.7%) patients having cervical lymphadenopathy at presentation and these initially presented to
the general surgeons. Twenty six (68.4%) patients had open cervical lymph node biopsy and 12/38
(31.6%) patients had FNAB. Eleven (28.9%) patients presented to the otolaryngology unit 6 months
after they presented to the general surgeons and 27 (71.1%) patients beyond 6 months. Nine deaths
were recorded. Ten patients were lost to follow-up.
Conclusion: All patients with head and neck lymphadenopathy who present to any physician for
diagnostic examination should undergo formal ENT staging and FNAB to avoid the problems of
tumor spread and the reduction in consequent prognosis.
Background
Cervical lymph node metastasis can be the first manifesta-
tion of a carcinoma. The corresponding primary tumor is
diagnosed in the ear, nose and throat region in 80% of
cases and the bronchi or esophagus in 10% of cases [1].
Therefore, a thorough otorhinolaryngological examina-
tion supplemented by imaging studies and panendoscopy
with directed biopsies of the suspicious primary sites must
be undertaken for diagnosis, staging and grading [2].
In the assessment of patients with cervical lymph node
enlargement, history and full clinical examination is
essential [3]. This is supplemented by radiological diag-
nostic facilities like computerized tomographic (CT) scan,
magnetic resonance imaging (MRI) and an examination
under anesthesia [4,5]. Further assessment with fine nee-
dle aspiration biopsy (FNAB) and an open biopsy can
help to confirm or refute the diagnosis of a head and neck
malignancy [6,7].
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Open cervical lymph node biopsy can alter patterns of
lymphatic drainage for up to 1 year following surgery but
does not portend a poor prognosis provided adequate and
early treatment is subsequently given [8]. This however
cannot be the same in our environment where it is com-
mon for patients to present late to the hospital. This late
presentation is usually attributed to ignorance and pov-
erty [9] and the final outcome is further worsened by the
unavailability of proper diagnostic and therapeutic facili-
ties to effectively manage these patients.
This paper focuses on the influence of open cervical
lymph node biopsy on the outcome of patients with head
and neck cancers in an ill-equipped tropical hospital set-
ting.
Methods
This is a ten-year (July 1998 to June 2008) retrospective
study of patients presenting with various types of head
and neck cancers to the otorhinolaryngology unit of the
Department of Surgery, Jos University Teaching Hospital,
Jos, Nigeria.
After obtaining approval from the Ethical Clearance Com-
mittee of the Jos University Teaching Hospital, the medi-
cal records of these patients were retrieved and analyzed
for age, sex, nodal stage of disease at presentation, diag-
nostic protocol and treatment outcome.
The results are presented in a tabular form.
Results
A total of 89 patients with head and neck cancers were
managed aged between 23 years and 78 years. There were
65 (73.0%) males and 24 (27.0%) females with a male to
female ratio of 2.7:1. Table 1 shows the representation of
the various types of head and neck cancers seen. Thirty
eight (42.7%) patients had cervical lymph node enlarge-
ment at presentation. Twenty nine (76.3%) patients had
nasopharyngeal cancer, 6 (15.8%) had oropharyngeal
cancer and 3 (7.9%) had sino-nasal cancers (Table 2).
Twenty one (55.3%) patients presented to the general sur-
geons with N1 nodal disease, 12 (31.6%) patients with
N2a nodal disease and 5 (13.2%) patients with N2b
nodal disease. The duration between disease onset and
presentation ranged from 8 to 15 months.
Four (4.5%) patients were able to afford CT scan.
Twenty six (68.4%) of the 38 patients who presented with
cervical lymphadenopathy were subjected to open cervical
lymph node biopsy by the general surgeons who were the
first contact health personnel in our tertiary health center.
The results from the pathologists which took a minimum
of two weeks were reported as inconclusive and an advice
for further evaluation of the patients to search for prima-
ries in the head and neck. Twelve (31.6%) patients had
FNAB with 9 positive for malignancy. All patients sus-
tained scar following open biopsy, 15 (57.7%) had tumor
spread.
Thirty eight patients presented to the otolaryngology unit
and 37 of them had endoscopic biopsy of their primary
tumors under general anesthesia (Table 3) and referred for
radiotherapy. One patient with nasopharyngeal cancer
died before he could have endoscopic biopsy. Eleven
(28.9%) patients presented to the otorhinolaryngology
unit after 6 months of first presentation to the general sur-
geons and 27 (71.1%) beyond 6 months. Nine deaths
were recorded i.e. mortality rate of 10.1%. Five (55.6%)
deaths were due to cancer, 3 (33.3%) from co-morbid
conditions and in 1(11.1%), the cause of death was
unknown. Ten patients were lost to follow-up, a common
practice in our environment attributed to the inability of
our patients to keep up with follow-up visits due to lack of
finance.
Discussion
An important prognostic factor for cancers of the head
and neck is the presence or absence, level and size of met-
astatic neck disease [10].
Both tumor and patient factors affect the pattern of spread
of malignant disease to the neck [11]. The primary site of
a tumor is important, with some sites having a high inci-
dence of metastases than others at presentation.
Table 1: Frequencies of Head and neck cancers seen








Table 2: Patients with cervical lymph node enlargement at 
presentation
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Lindberg in 1972 was able to establish the possibility of
predicting the site of a primary tumor in the head and
neck based on the distribution of cervical metastasis [12].
Following this, the Memorial Sloan-Kettering Hospital in
1981 published 7 levels or regions in the neck which con-
tain groups of lymph nodes that represent the first eche-
lon sites for metastasis from head and neck primary
tumors [13]. For example, the nasopharynx, nasal cavities
and paranasal sinuses drain via the junctional nodes into
the upper deep cervical lymph nodes in levels II-III... e.t.c.
The management of a patient with cervical lymph node
enlargement starts with a history of the disease, full clini-
cal examination, and radiological investigations such as
CT scan, MRI, ultrasound and radionuclide scanning
[3,4]. These are supplemented by an examination under
anesthesia and panendoscopy to look for the primary site
of tumor with biopsies of suspicious tumor sites [5].
Fine needle aspiration biopsy is preferable to open biopsy
of a cervical lymph node for the reasons that there is no
tumor spread, no inconvenient scar to distort future surgi-
cal intervention, no delay between diagnosis and treat-
ment and its simplicity. When a diagnosis of malignancy
cannot be made by needle biopsy, then an open biopsy
can be done provided it can be followed by a frozen sec-
tion and a concomitant definitive neck dissection if per-
operative positive histological diagnosis is obtained [14].
Open cervical lymph node biopsy can alter patterns of
lymphatic drainage for up to 1 year following surgery [8]
and creates a scar which distorts future surgical interven-
tion therefore altering the outcome of treatment [14].
Table 3: Histological diagnosis and staging in patients with cervical lymphadenopathy
Diagnosis Clinical Stage Path. Stage Site
1 Papillary SCC 3 4a Oropharynx- R tonsil
2 Non-keratinizing SCC 3 4a Nasopharynx- L wall
3 Well-differentiated SCC 3 3 Nasopharynx- L wall
4 Well-differentiated SCC 3 4a Nasopharynx
5 Un-differentiated SCC 4a 4b Nasopharynx- L wall
6 Un-differentiated SCC 3 4b Oropharynx- soft palate
7 Rhabdomyosarcoma 3 3 Nasopharynx
8 Well-differentiated SCC 3 3 Nasopharynx- R wall
9 Non-Hodgkin's Lymphoma 3 3 L max. sinus
10 Non-Hodgkin's Lymphoma 4b 4b Oropharynx- L tonsil
11 Un-differentiated SCC 4a 4b Nasopharynx
12 Keratinizing SCC 3 3 Nasopharynx
13 Well-differentiated SCC 3 3 Nasopharynx- R wall
14 Poorly-differentiated SCC 3 4a Nasopharynx
15 Well-differentiated SCC 3 3 Nasopharynx- R wall
16 Well-differentiated SCC 3 3 Nasopharynx- L wall
17 Adenocarcinoma 4a 4b R nose
18 Well-differentiated SCC 3 4a Nasopharynx
19 Non-Hodgkin's Lymphoma 3 3 Oropharynx- R tonsil
20 Lymphoepithelioma 3 3 Nasopharynx
21 Un-differentiated SCC 3 4a Nasopharynx- L wall
22 Well-differentiated SCC 3 3 Nasopharynx
23 Non-keratinizing SCC 3 4a Nasopharynx
24 Well-differentiated SCC 3 3 Nasopharynx
25 Poorly-differentiated SCC 3 3 Nasopharynx- R wall
26 Poorly-differentiated SCC 4a 4b Nasopharynx- R wall
27 Well-differentiated SCC 3 3 Nasopharynx- L wall
28 Poorly-differentiated SCC 3 4b Oropharynx- R tonsil
29 Non-keratinizing SCC 3 3 Nasopharynx
30 Non-Hodgkin's Lymphoma 4a 4a Oropharynx- L tonsil
31 Well-differentiated SCC 3 3 Nasopharynx- L wall
32 Non-keratinizing SCC 3 4b Nasopharynx
33 Un-differentiated SCC 3 4a Nasopharynx- R wall
34 Well-differentiated SCC 3 3 Nasopharynx
35 Unknown 3
36 Poorly-differentiated SCC 4b 4b R ethm.sinus
37 Un-differentiated SCC 4a 4b Nasopharynx
38 Well-differentiated SCC 3 3 Nasopharynx
Key: R-right, L-left, SCC-squamous cell carcinoma, Ethm.-ethmoid, Path.-pathologicalHead & Neck Oncology 2009, 1:9 http://www.headandneckoncology.org/content/1/1/9
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In our environment, the interplay of several factors con-
tributes to the poor outcome in the management of head
and neck cancer patients. These factors include late patient
presentation, inaccessible health facilities and delay in the
availability of histopathology results following biopsies.
Our study shows that our head and neck cancer patients
presented late to the hospital which is a common feature
here attributed to poverty and ignorance [9].
All the patients in our study were referred to the general
surgeons by health workers from neighboring primary
health centers which explains why they were the first con-
tact health personnel in our tertiary health center.
Facilities for frozen section are not available in our center
and delay in getting histopathology results from the open
cervical biopsies further compounds our patients' prob-
lems as their tumors and disease process progresses fur-
ther with advanced nodal diseases on presentation to the
otorhinolaryngologist who is left with little or no help to
offer these patients at the time they present.
Even though FNAB done for 12 of our patients was able to
detect malignancy in 9 patients, all had examination
under anesthesia to detect the site of primary tumor and
to be able to get biopsy material for histological diagnosis.
Knowing the site of primary tumor is essential in planning
treatment. However, in this study it is not clearly stated by
the general surgeons the criteria used for subjecting some
patients to open biopsy and others to FNAB.
Majority of our people cannot afford the cost of diagnostic
facilities like CT scan. This is further buttressed by the fact
that only four patients in our series could afford it-
patients number 24, 25, 31 and 38 as seen on Table 3
below. These patients benefitted from this radiological
diagnosis and are still alive following treatment.
Nine deaths were recorded in our series. These are shown
on Table 3 to be patients' number 5, 6, 10, 11, 26, 32, 35,
36 and 37 who had advanced disease. Three of these also
had co-morbid medical conditions (hypertension and
diabetes mellitus) and 1 (patient number 35) died before
he could have endoscopic biopsy.
The mortalities recorded in our series were all as a result
of interplay of the above mentioned factors. To overcome
these, we recommend that all head and neck cancer
patients especially those with cervical lymph node
enlargement on presentation should have an examination
under anesthesia and endoscopic biopsies taken from all
suspicious primary tumor sites to obtain histological diag-
nosis rather than be subjected to open cervical lymph
node biopsy. This enables planning for early and proper
treatment. This can be done by the first contact health per-
sonnel or a referral to the otorhinolaryngologist or head
and neck oncologist to avoid delay in patient manage-
ment and to institute early treatment.
Conclusion
While we await improvements in the diagnostic and ther-
apeutic facilities for the care of patients with head and
neck cancers in our environment, we recommend that all
patients with head and neck lymphadenopathy who
present to any physician for diagnostic examination
should undergo formal ENT staging and FNAB to avoid
the problems of tumor spread and the reduction in conse-
quent prognosis.
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